- $1.41bn
- -$368.63m
- CNY5.95bn
- 69
- 84
- 95
- 96
2019 December 31st | 2020 December 31st | 2021 December 31st | 2022 December 31st | 2023 December 31st | |
---|---|---|---|---|---|
Period Length: | 12 M | 12 M | 12 M | 12 M | 12 M |
Source: | PROSPECTUS/A | PROSPECTUS/A | 20-F | 20-F | 6-K |
Standards: | USG | USG | USG | USG | — |
Status: | Final | Final | Final | Final | Final |
Revenue | |||||
Total Revenue | 999 | 1,944 | 4,259 | 4,511 | 5,952 |
Cost of Revenue | |||||
Gross Profit | 861 | 1,704 | 3,704 | 3,756 | 4,892 |
Selling / General / Administrative Expenses | |||||
Research And Development | |||||
Unusual Expense / Income | |||||
Other Operating Expenses | |||||
Total Operating Expenses | 1,511 | 2,889 | 5,295 | 4,641 | 5,371 |
Operating Profit | -512 | -945 | -1,036 | -130 | 581 |
Total Net Non Operating Interest Income / Expense | |||||
Other Net Non Operating Costs | |||||
Net Income Before Taxes | -502 | -942 | -1,012 | 117 | 1,222 |
Provision for Income Taxes | |||||
Net Income After Taxes | -502 | -942 | -1,071 | 107 | 1,099 |
Minority Interest | |||||
Net Income Before Extraordinary Items | |||||
Net Income | -502 | -942 | -1,071 | 107 | 1,099 |
Adjustments to Net Income | |||||
Income Available to Common Shareholders Excluding Extraordinary Items | |||||
Income Available to Common Shareholders Including Extraordinary Items | |||||
Diluted Net Income | -734 | -1,226 | -1,235 | 107 | 1,099 |
Diluted Weighted Average Shares | |||||
Basic EPS Including Extraordinary Items | |||||
Diluted EPS Including Extraordinary Items | |||||
Diluted EPS Excluding Extraordinary Items | |||||
Normalised Income Before Taxes | |||||
Normalised Income After Taxes | |||||
Normalised Income Available to Common Shareholders | |||||
Diluted Normalised EPS | -0.921 | -1.54 | -1.43 | 0.118 | 1.22 |